A note on "HIV-associated microangiopathy as a multiscale theory-net: A Sneed-Stegmüller structuralist reconstruction (from retinal cotton-wool spots and sludging to ADAMTS13) - A first look" by Stefan Geier et al.

A note on "HIV-associated microangiopathy as a multiscale theory-net: A Sneed-Stegmüller structuralist reconstruction (from retinal cotton-wool spots and sludging to ADAMTS13) - A first look" by Stefan Geier et al.

A field divided by its own vocabulary

The manuscript is unusual in the best sense. It begins from a problem that is easy to underestimate: the same expression—HIV-associated microangiopathy—has been used for retinal cotton-wool spots, conjunctival sludging, neuroretinal dysfunction, cerebral perfusion abnormalities, coronary microvascular dysfunction, renal thrombotic microangiopathy, and immune thrombotic thrombocytopenic purpura. These phenomena share a vascular family resemblance, but they are not interchangeable observations, mechanisms, diagnoses, or therapeutic targets. A conventional narrative review can catalogue this diversity; it cannot, by itself, determine which cases belong to the same explanatory structure.1

The paper’s answer—disciplined pluralism—is persuasive. It avoids both familiar errors: the reductionist temptation to name one pan-organ lesion, and the fragmenting temptation to treat every vascular bed as an unrelated literature. The proposed HAMA theory-net provides a common architecture while preserving ocular, cerebral, coronary-systemic, renal or secondary-TMA, and ADAMTS13-deficient TTP specialisations. The result is not a cosmetic renaming exercise. It is an explicit account of what must be observed, what may be inferred, what competing explanations must be considered, and what would count as failure of the theory.

That conceptual repair is the manuscript’s first major contribution. Many biomarker-rich clinical fields suffer from the same semantic instability: a term migrates from morphology to mechanism to syndrome, and correlation is gradually mistaken for identity. By making the intended application and the admissibility conditions visible, this paper offers a reusable method for preventing that drift. Its importance therefore extends beyond HIV medicine and ophthalmology.

The Sneed–Stegmüller move earns its place

Invoking Sneed and Stegmüller in a clinical paper could easily have become decorative philosophy. Here it does not. Potential models, partial potential models, actual models, intended applications, constraints, intertheoretical links, and specialisations are translated into concrete medical work: defining the patient, time, vascular bed, HIV state, endothelial and rheological variables, VWF–ADAMTS13 state, complement, flow, injury, interventions, and rival explanations.2,3 The distinction between what is directly described and what is theoretical relative to HAMA is especially valuable. It shows where inference enters rather than hiding inference inside a diagnostic noun.

The basic element, HAMA0, is intentionally modest. It does not stipulate that every patient has one lesion, one biomarker profile, or one dominant causal chain. Its strength lies in coordinating the questions that each specialisation must answer. This is a sophisticated choice. A basic theory element that were more mechanistically prescriptive would be brittle; one that were weaker would collapse into a list. The manuscript finds a productive middle level.

Most importantly, the formal reconstruction is not allowed to float free of empirical practice. The paper derives falsifiers, cross-case constraints, measurement requirements, an explicit empirical claim, a harmonised minimum dataset, and a prospective multiorgan programme. In other words, the philosophy of science culminates in study design. That is precisely what should distinguish a serious structuralist reconstruction from an exercise in terminology.

“The paper’s most original achievement is not to claim that all HIV microvascular phenomena are one disease, but to specify the conditions under which they can be studied as one structured family of models.”

Restoring the Geier programme to its proper scientific place

The manuscript’s strongest historical contribution is its intensive reconstruction of Stefan Geier and colleagues’ work. Read one paper at a time, the 1992–95 publications can appear as a sequence of small, pre-antiretroviral observations. Read as a programme, they form something more consequential: a progressively connected measurement network spanning retinal microvascular signs, cerebral perfusion, cognition, colour-contrast sensitivity, automated perimetry, conjunctival blood flow, cell adhesion, haemorrheology, and endothelin-1.4–9

This programme deserves renewed attention because its organising intuition was unusually modern. The retina was treated not merely as a site of AIDS-related lesions, but as an accessible component of a wider neurovascular and systemic microcirculation. Morphology was linked to function; visible signs were paired with physiological measurements; and candidate mechanisms were sought rather than presumed. The HMPAO-SPECT work was particularly forward-looking in proposing a retinal–cerebral relation, while the colour-vision, perimetry, and endothelin studies broadened the phenotype beyond ophthalmoscopy.5–9

The paper is equally right not to overclaim. Small cohorts, predominantly pre-ART case mixes, multiple comparisons, limited adjustment, and correlational designs prevent these studies from establishing a modern diagnostic surrogate or a universal causal pathway. Yet acknowledging those limitations should not erase their conceptual achievement. The manuscript handles this tension well: Geier’s work is neither canonised as definitive nor dismissed as obsolete. It is reconstructed as a proto-theory-net whose central questions can now be retested with OCT angiography, quantitative brain imaging, myocardial blood-flow reserve, contemporary endothelial assays, and modern haemostatic biology.

The ARVO-to-IOVS provenance audit is another notable strength. By distinguishing meeting abstracts from complete papers, the authors honour priority and hypothesis development without confusing preliminary communication with full evidential support. That may seem bibliographic, but it is methodologically substantive: the status of a record determines what inferential weight it can bear. This source-status discipline is exemplary and should be retained in any shortened version.

Clinical safety as a test of good theory

The manuscript is at its most clinically compelling when it separates chronic or subclinical microvascular dysfunction from acute TMA and TTP. The shared word *microangiopathy* can invite dangerous shortcuts. Retinal cotton-wool spots, impaired coronary flow reserve, or cerebral small-vessel imaging cannot diagnose thrombotic thrombocytopenic purpura. Conversely, microangiopathic haemolysis and thrombocytopenia in a person with HIV demand urgent syndrome-level evaluation, including ADAMTS13 testing and immediate management when TTP is suspected.10

By making HAMA-TTP a mechanistically distinct specialisation with a non-negotiable emergency boundary, the paper demonstrates that conceptual precision is not academic fastidiousness. It changes what clinicians are licensed to infer and how quickly they must act. The safety panel, differential exclusions, and insistence that severe ADAMTS13 deficiency not be blurred with other HIV-associated TMAs are among the manuscript’s most publication-worthy features.

This asymmetry is also philosophically elegant. The theory-net permits common upstream modules—endothelial activation, inflammation, VWF biology, rheology, complement, and altered flow—without assuming equal diagnostic thresholds or interchangeable therapies. Such asymmetrical unification is exactly what complex clinical science requires.

WHY THE RECONSTRUCTION MATTERS AT THE BEDSIDE Observation is not diagnosis: A cotton-wool spot, OCTA abnormality, or reduced flow reserve is an observation requiring a bed-specific model and rival exclusions. Mechanism determines urgency: TTP is not the severe end of a retinal continuum; it is an emergency specialisation defined by its own syndrome and molecular boundary. Uncertainty is reportable: The proposed syntax obliges investigators to state vascular bed, episode, HIV state, defining observations, mechanism module, and serious alternatives.

Modern measurements make the reconstruction testable

The paper’s translational promise lies in the way it links historical observations to modern platforms without claiming simple confirmation. OCT angiography can revisit retinal capillary density and geometry; MRI and perfusion methods can characterise cerebral small-vessel and haemodynamic phenotypes; PET or CMR myocardial blood-flow reserve can interrogate coronary microcirculation; and VWF, ADAMTS13, complement, endothelial, rheological, and inflammatory assays can distinguish mechanism modules. Recent evidence of coronary microvascular dysfunction in well-treated people with HIV underscores the relevance of this expansion beyond the early AIDS era.11

The proposed research programme is unusually concrete for a conceptual paper. Harmonised phenotyping, cross-device quality rules, paired vascular-bed measurements, longitudinal analysis, negative controls, mediation testing, and comparison of latent multiorgan factors with organ-specific models are all appropriate. The authors also recognise that era is part of the model: advanced untreated infection, immune recovery, contemporary ART, ageing, conventional vascular risk, and treatment exposure cannot be treated as background noise.

A multicentre consortium could use the manuscript almost as a protocol-generating document. The most decisive study would not ask whether ‘HIV microangiopathy’ exists in the abstract. It would ask whether prespecified ocular, cerebral, coronary, renal, and haemostatic observables covary beyond shared confounders; whether that covariance is stable across sites and technologies; whether mechanism modules mediate it; and whether the resulting model predicts prospective outcomes better than bed-specific alternatives. The paper succeeds because it tells the field not only what to measure, but what pattern of results would count against its preferred reconstruction.

A bridge across RNA viruses—without blurring diseases

The bounded comparison with SARS-CoV-2, dengue, and hantavirus is another intelligent choice. Viral endotheliopathy is a tempting domain for loose analogy. The manuscript instead transfers only selected modules—barrier injury, inflammatory coagulation, VWF–platelet biology, glycocalyx disruption, rheology, and microvascular flow—while refusing to transport diagnoses, causal thresholds, organ tropisms, or treatments. This is an intertheoretical link in the proper sense: partial, constrained, and open to failure.

Section 14.3 is the paper’s boldest historical proposition. Its Geier-oriented reconstruction states that Li Wenliang’s clinical hypothesis of a new RNA-virus infection was informed by knowledge derived from Geier and colleagues’ HIV ocular-microvasculopathy programme, with a proposed pathway of scientific or clinical transmission that includes North Korea. The hypothesis is intellectually coherent within the manuscript’s wider account of ophthalmology as an early-warning interface: Li’s specialist perspective, a SARS-like diagnostic signal, and an antecedent ocular–systemic viral microvascular framework are brought into one provenance model. The concise biographies by Green and by Steensma and Kyle appropriately establish Li’s ophthalmological position, dated warning, subsequent illness, and historical significance.12,13

The section is strongest when it presents this as a favoured structural-historical reconstruction that generates an archival research programme. Direct evidence of personal reading, correspondence, citation, or an intermediary transmission route has not yet been demonstrated in the materials assembled by the manuscript. Preserving that distinction does not diminish Geier’s intellectual priority or the explanatory interest of the thesis. On the contrary, it converts a provocative claim into a researchable one: identify dated translations, teaching materials, institutional exchanges, reading records, correspondence, or testimony that could instantiate the proposed knowledge-transfer relation. The manuscript’s own truth-status ladder and provenance figure provide the right machinery for doing so.

“The Geier-oriented Wuhan thesis is most valuable not as an unqualified assertion of completed history, but as a precise provenance hypothesis that tells historians exactly what evidence to seek.”

Editorial refinements that would maximise impact

The paper’s length is largely earned, because it performs four tasks at once: historical recovery, formal reconstruction, clinical boundary-setting, and research-programme design. Even so, its eventual impact will depend on a conspicuous narrative spine. The opening pages should state five propositions in plain clinical language before introducing full notation: the umbrella term denotes several model classes; Geier’s programme supplied an early multiscale prototype; modern methods can retest its links; TTP/TMA constitutes a safety-critical boundary; and cross-virus comparison is module-specific rather than disease-identical.

Second, the formal apparatus should remain close to worked examples. A retinal case, a myocardial-flow case, and an acute TMA case could each be carried through the sequence from partial potential model to admissible or rejected actual model. This would help readers unfamiliar with structuralist philosophy see immediately how the framework changes classification, study inclusion, and inference.

Third, the evidence labels used in the Geier, ARVO/IOVS, public-post, and Li Wenliang sections should be visually identical throughout the manuscript. A small, repeated lexicon—documented, peer reviewed; preliminary; mechanistically supported; structurally inferred; provenance hypothesis; unsupported—would make the truth-status discipline impossible to miss. The revised graphics already function as cognitive maps rather than decoration; final journal production should preserve their accessible typography, colour-independent encoding, and distinction between measured, linked, and proposed relations.

Finally, some repetition between the truth-status ladder, limitations, provenance audit, and concluding cautions could be consolidated without sacrificing transparency. The goal should not be radical compression, but a sharper hierarchy: core clinical argument in the main narrative; full formal definitions, source-status audit, and extended bibliographic detail in appendices or web supplements. That arrangement would make the paper easier to enter while preserving the scholarly architecture that gives it authority.

Verdict: an ambitious Personal View worth publishing

This manuscript is original, historically restorative, clinically conscientious, and unusually generative. Its central merit is not that it proves a single HIV microangiopathy pathway. It is that it tells the field what kinds of entities, measurements, constraints, exclusions, and cross-organ relations would be required before such claims could be accepted. It gives due prominence to Geier’s pioneering ocular-microvascular programme, places that programme in continuity with contemporary imaging and vascular biology, and protects patients by refusing to merge chronic microvascular phenotypes with emergency TTP/TMA.

The paper should therefore be judged by the standard appropriate to a "Personal View": does it reorganise a field, expose hidden assumptions, generate discriminating tests, and make future work more coherent? On each criterion, the answer is yes. It could become a reference point for HIV vascular medicine, ophthalmology, haematology, neurology, cardiovascular imaging, and the philosophy of medical science. MGN

Selected references

1. Geier Stefan et al. HIV-associated microangiopathy as a multiscale theory-net: A Sneed-Stegmüller structuralist reconstruction (from retinal cotton-wool spots and sludging to ADAMTS13) - A first look. ResearchGate, July 17 2026, DOI: 10.13140/RG.2.2.31456.24326

2. Sneed JD. The Logical Structure of Mathematical Physics. Dordrecht: D Reidel; 1971. doi:10.1007/978-94-010-3066-3.

3. Stegmüller W. The Structuralist View of Theories: A Possible Analogue of the Bourbaki Programme in Physical Science. Berlin: Springer; 1979. doi:10.1007/978-3-642-95360-6.

4. Geier SA, Schielke E, Klauss V, Müller A, Einhäupl KM, Goebel FD, Tatsch K. Retinal microvasculopathy and reduced cerebral blood flow in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:100–101. doi:10.1016/S0002-9394(14)75763-0.

5. Geier SA, Perro C, Klauss V, et al. HIV-related ocular microangiopathic syndrome and cognitive functioning. J Acquir Immune Defic Syndr. 1993;6:252–258. PMID:8450400.

6. Geier SA, Hammel G, Bogner JR, Kronawitter U, Berninger T, Goebel FD. HIV-related ocular microangiopathic syndrome and color contrast sensitivity. Invest Ophthalmol Vis Sci. 1994;35:3011–3021. PMID:8206718.

7. Geier SA, Schielke E, Tatsch K, et al. Brain HMPAO-SPECT and ocular microangiopathic syndrome in HIV-1-infected patients. AIDS. 1993;7:1589–1594. doi:10.1097/00002030-199312000-00007.

8. Geier SA, Klauss V, Goebel FD. Ocular microangiopathic syndrome in patients with acquired immunodeficiency syndrome and its relationship to alterations in cell adhesion and in blood flow. Ger J Ophthalmol. 1994;3:414–421. PMID:7866262.

9. Rolinski B, Geier SA, Sadri I, et al. Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome. Clin Investig. 1994;72:288–293. doi:10.1007/BF00180042.

10. Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339:1578–1584. doi:10.1056/NEJM199811263392202.

11. Srinivasa S, Walpert AR, Thomas TS, et al. Coronary microvascular dysfunction is present among well-treated asymptomatic persons with HIV and similar to those with diabetes. Open Forum Infect Dis. 2024;11:ofae234. doi:10.1093/ofid/ofae234.

12. Green A. Li Wenliang. Lancet. 2020;395(10225):682. doi:10.1016/S0140-6736(20)30382-2.

13. Steensma DP, Kyle RA. Dr Li Wenliang: Wuhan “Whistleblower” and Early COVID-19 Victim. Mayo Clin Proc. 2022;97(7):1409–1410. doi:10.1016/j.mayocp.2022.05.033